Progress in the design and development of phosphoinositide 3-kinase (PI3K) inhibitors for the treatment of chronic diseases.

Progress in medicinal chemistry

Volumn 48, Issue , 2009, Pages 81-131

  Shuttleworth, Stephen ^a   Silva, Franck ^b   Tomassi, Cyrille ^b   Cecil, Alexander ^b   Hill, Thomas ^b   Rogers, Helen ^b   Townsend, Paul ^b  

^a Southampton Science Park   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE INHIBITOR;

ANIMAL; CHRONIC DISEASE; DRUG ANTAGONISM; DRUG DESIGN; HUMAN; NEOPLASM; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CHRONIC DISEASE; DRUG DESIGN; HUMANS; NEOPLASMS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN KINASE INHIBITORS; SIGNAL TRANSDUCTION;

EID: 77953719346     PISSN: 00796468     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0079-6468(09)04803-6     Document Type: Review

References (0)